Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4, which inhibits both ristocetin- and botrocetin-induced vWF binding to platelet glycoprotein Ib
Yoshihiro Fujimura(Japanese Red Cross Society, Japan), Hiromu Fukui(National Archives and Records Administration), Koiti Titani(Gifu Pharmaceutical University), Kenji Nishio(Fujita Health University), Akira Yoshioka(Kyoto University), T Takase(Nara Medical University), K. Niinomi(Nara Medical University), Yoshiko Usami(University of Massachusetts Chan Medical School)
Cited by 68
Related Papers
Human Recombinant DNA–Derived Antihemophilic Factor (Factor VIII) in the Treatment of Hemophilia A
|New England Journal of Medicine|1990|266
Structural Basis for Budding by the ESCRT-III Factor CHMP3
|Developmental Cell|2006|254
Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface
|Biochemical Journal|1993|213
Release of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 budding
|Proceedings of the National Academy of Sciences|2006|182